Abbott India Q1 net up 71% to Rs 51 cr

Tags: Companies
Drug firm Abbott India today posted 71.42 per cent rise in its net profit to Rs 50.93 crore for the first quarter ended June 30.

The company had posted a net profit of Rs 29.71 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 516.91 crore for the first quarter, as compared to Rs 429.68 crore during the same period of previous fiscal, Abbott India Ltd said in a filing to the BSE.

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

These transactions made it one of the largest health care companies in the country. It now employs about 14,000 people in India, making it the firm's largest employee base outside the US.

Shares of Abbott India were trading at Rs 2,330 apiece on the BSE, up 7.08 per cent from its previous close.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • Govt can’t clamp down on voices that ask uneasy questions

    It has hardly been a peaceful annum for Greenpeace’s India arm that has been in and out of trouble over the last one year.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Varun Dutt

<b>Risk Factor:</b> The blame game

In decision-making, the fundamental attribution error (FAE), also known as ...

Zehra Naqvi

Dignity of labour is dignity of life

M Rafi Khan, a retired police IG, used to ...

Gautam Gupta

Retailers have it tough, thanks to e-commerce

For the past few months our focus has been on ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture